Indication

Serratia pneumonia

Serratia pneumonia is a lower respiratory tract infection caused by Gram-negative bacilli of the genus *Serratia*, most frequently *Serratia marcescens*. Read more about Serratia pneumonia

95 drugs 50 manufacturers

Advertisement

Drugs that treat it

Common Serratia pneumonia therapies.

Showing 64–72 of 95 drugs

AMIKACIN SULFATE

AMINOGLYCOSIDES, PARENTERAL·STAPHYLOCOCCAL SEPTICEMIA·+60
Hikma Pharmaceuticals USA

GENTAMICIN SULFATE

AMINOGLYCOSIDES, PARENTERAL·SEPSIS CAUSED BY ENTEROBACTER·+63
EUGIA US LLC
Filter & compare in the drug finder →Opens the drug finder with Serratia pneumonia preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Serratia pneumonia.

Serratia pneumonia is a lower respiratory tract infection caused by Gram-negative bacilli of the genus *Serratia*, most frequently *Serratia marcescens*.

Primarily manifesting as a healthcare-associated or hospital-acquired pneumonia, it disproportionately affects hospitalized patients, individuals receiving mechanical ventilation, immunocompromised hosts, and patients with severe chronic cardiopulmonary disease.

Pathophysiologically, the infection is characterized by acute necrotizing bronchopneumonia, alveolar exudation, and pulmonary hemorrhage, frequently resulting in microabscess formation, lung cavitation, and empyema.

Affected patients typically present with acute fever, hypoxemia, purulent or blood-tinged sputum, and patchy bronchopneumonic infiltrates or consolidations on pulmonary imaging.

Personalize your experience

Follow Serratia pneumonia and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it